TITLE

Ethnicity as a factor in adverse reactions to cardiovascular drugs

PUB. DATE
August 2006
SOURCE
Nursing Standard;8/9/2006, Vol. 20 Issue 48, p17
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the research that ethnicity is a factor in adverse reactions to cardiovascular drugs. The study conducted by the researchers from Birmingham set about a systematic review and meta-analysis on two ethnic groups. Out of the 364 total studies which gave some description of ethnicity and an adverse reaction, 132 are related to cardiovascular drugs, while data for adverse reactions for at least two ethnic groups in 24 studies were found.
ACCESSION #
22032637

 

Related Articles

  • TLR1, 2, 4, 6 and 9 Variants Associated with Tuberculosis Susceptibility: A Systematic Review and Meta-Analysis. Schurz, Haiko; Daya, Michelle; Möller, Marlo; Hoal, Eileen G.; Salie, Muneeb // PLoS ONE;10/2/2015, Vol. 10 Issue 10, p1 

    Background: Studies investigating the influence of toll-like receptor (TLR) polymorphisms and tuberculosis susceptibility have yielded varying and often contradictory results in different ethnic groups. A meta-analysis was conducted to investigate the relationship between TLR variants and...

  • Ethnicity a risk factor for cardiovascular drug-induced AEs?  // Reactions Weekly;5/20/2006, Issue 1102, p5 

    Discusses research which analyzed ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. Reference to a study by S. E. McDowell and colleagues, published in the May 5, 2006 issue of the "British Medical Journal" online version; Difference between black and...

  • Some Salt with Your Statin, Professor? Macleod, Malcolm // PLoS Biology;Jan2014, Vol. 12 Issue 1, p1 

    In this primer, Malcolm Macleod outlines the use of meta-analysis to assess the validity of the outcome reported for preclinical studies and explores the reasons why Lisa Bero and colleagues find that industry-funded studies show smaller effect sizes than non-industry-funded studies do.

  • Ethnicity and adverse drug reactions. Eliasson, Erik // BMJ: British Medical Journal (International Edition);5/20/2006, Vol. 332 Issue 7551, p1163 

    The article discusses whether ethnicity is a factor in the outcome of drug treatment. It considers the facts that skin color and self identification of ethnicity often have a small correlation to molecular genetics, and that most genetic variation is found within continental populations....

  • Community-Based Colorectal Cancer Screening Trials with Multi-Ethnic Groups: A Systematic Review. Morrow, Jay B.; Dallo, Florence J.; Julka, Manjula // Journal of Community Health;Dec2010, Vol. 35 Issue 6, p592 

    The objective of this review was to summarize the current literature of community-based colorectal cancer screening randomized controlled trials with multi-ethnic groups. The CDC reports 40% of adults do not receive time-appropriate colorectal cancer screening. Although overall screening rates...

  • Tofacitinib for acute rheumatoid arthritis patients who have had an inadequate response to disease-modifying antirheumatic drug (DMARD): a systematic review and meta-analysis. Zhang, Xingming; Liang, Fuxiang; Yin, Xiaoxue; Xiao, Xiaojuan; Shi, Peiyu; Wei, Dang; Yao, Liang; Wang, Qi; Chen, Yaolong // Clinical Rheumatology;Feb2014, Vol. 33 Issue 2, p165 

    The aim of this systematic review and meta-analysis is to assess the efficacy and safety of tofacitinib for the treatment of patients with acute rheumatoid arthritis (RA) who have had an inadequate response to disease-modifying antirheumatic drug (DMARD). Randomized controlled trials were...

  • Oral care in ICU patients: a review of research evidence. M., Adib-Hajbaghery; A., Ansari; I., Azizi-Fini // Feyz Journal of Kashan University of Medical Sciences;Nov2011, Vol. 15 Issue 3, p280 

    Background: Considering the importance of oral care in the ICU and the lack of comprehensive protocols for oral care, the present study was conducted to review the available literature on oral care and to present an evidence-based protocol for oral care in ICU patients. Materials and Methods:...

  • Clinical Association Between Pharmacogenomics and Adverse Drug Reactions. Zhou, Zhi-Wei; Chen, Xiao-Wu; Sneed, Kevin; Yang, Yin-Xue; Zhang, Xueji; He, Zhi-Xu; Chow, Kevin; Yang, Tianxin; Duan, Wei; Zhou, Shu-Feng // Drugs;Apr2015, Vol. 75 Issue 6, p589 

    Adverse drug reactions (ADRs) are a major public health concern and cause significant patient morbidity and mortality. Pharmacogenomics is the study of how genetic polymorphisms affect an individual's response to pharmacotherapy at the level of a whole genome. This article updates our knowledge...

  • Need for standardising adverse event reporting in testosterone trials. Basaria, Shehzad // Evidence Based Medicine;Feb2014, Vol. 19 Issue 1, p32 

    The article discusses the need of standardizing adverse event reporting in randomized controlled trials of testosterone. It discusses hypogonadism, testosterone therapy and harmful effects of testosterone trials. It also discusses relationship between testosterone and cardiovascular disease,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics